Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267111/
https://www.ncbi.nlm.nih.gov/pubmed/34137814
http://dx.doi.org/10.1182/bloodadvances.2021005072
_version_ 1783720072268742656
collection PubMed
description
format Online
Article
Text
id pubmed-8267111
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-82671112021-07-12 Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153. Blood Adv Erratum American Society of Hematology 2021-06-17 /pmc/articles/PMC8267111/ /pubmed/34137814 http://dx.doi.org/10.1182/bloodadvances.2021005072 Text en © 2021 by The American Society of Hematology
spellingShingle Erratum
Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153.
title Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153.
title_full Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153.
title_fullStr Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153.
title_full_unstemmed Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153.
title_short Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153.
title_sort qi s-n, yang y, song y-q, et al. first-line non–anthracycline-based chemotherapy for extranodal nasal-type nk/t-cell lymphoma: a retrospective analysis from the clcg. blood adv. 2020;4(13):3141-3153.
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267111/
https://www.ncbi.nlm.nih.gov/pubmed/34137814
http://dx.doi.org/10.1182/bloodadvances.2021005072

Ejemplares similares